Completed PHASE3 INTERVENTIONAL 2-arm NCT01752322

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

Efficacy and Safety of Lidocaine 5% Medicated Plaster in Localized Chronic Post-operative Neuropathic Pain

Sponsor: Grünenthal GmbH

Conditions Chronic Pain Neuropathic Pain Pain Postoperative Pain

Interventions Lidocaine 5% medicated plaster Placebo plaster

Updated 6 times since 2017 Last updated: Jul 5, 2016 Started: Oct 31, 2012 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Pain and Neuropathic Pain, this trial is completed. The trial is conducted by Grünenthal GmbH and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Grünenthal GmbH

Data source: Grünenthal GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Barcelona, Spain , Barretos, Brazil , Bordeaux, France , Boulogne-Billancourt, France , Cardiff, United Kingdom , Copenhagen, Denmark , Florence, Italy , Glasgow, United Kingdom , Glostrup Municipality, Denmark and 25 more locations